Homœopathic Links 2019; 32(04): 251-255
DOI: 10.1055/s-0039-3402511
Case Report
Thieme Medical and Scientific Publishers Private Ltd.

Adenomyosis in a Perimenopausal Woman Treated by Potentized Poison Hemlock—A Case Report

Hima Bindu Ponnam
1  Extension Clinical Research Unit, Central Council for Research in Homoeopathy, Princess Durru Shehvar Children's and General Hospital, Hyderabad, Telangana, India
,
Nanda Kishori Ciluveru
1  Extension Clinical Research Unit, Central Council for Research in Homoeopathy, Princess Durru Shehvar Children's and General Hospital, Hyderabad, Telangana, India
,
Mohammed Irfan
1  Extension Clinical Research Unit, Central Council for Research in Homoeopathy, Princess Durru Shehvar Children's and General Hospital, Hyderabad, Telangana, India
,
Bharathi Chakali
1  Extension Clinical Research Unit, Central Council for Research in Homoeopathy, Princess Durru Shehvar Children's and General Hospital, Hyderabad, Telangana, India
› Author Affiliations
Further Information

Publication History

Publication Date:
07 January 2020 (online)

Abstract

Adenomyosis is a common pathological condition of the uterus where its diagnosis and treatment remain still a challenge to the treating physicians. Even though termed as benign, its clinical presentation of heavy, painful menstrual bleeding, infertility and hindrance to a women's quality of life makes it significant cause for treatment. The adenomyosis condition with significant symptoms is dealt with surgically in the conventional system of medicine by way of hysterectomy, uterine artery embolisation or endometrial ablation. These surgical interventions can be prevented with homoeopathic system of medicine. A case of adenomyosis in a 41-year-old female who presented with continuous heavy bleeding and severe pelvic pain was successfully treated with homoeopathy medicine, Conium maculatum, which is commonly called as poison hemlock. The medicine prescribed on totality alleviated not only symptoms of the patient but also resolved adenomyosis completely.

Consent for Publication

Oral and written consent has been taken from the patient.